Atcor Medical Holdings Limited : AtCor awarded $1.1 million Commercialisation Australia Grant

ASX release 2 February 2012

AtCor awarded $1.1 million Commercialisation Australia Grant

AtCor Medical (ASX:ACG), the developer and marketer of the SphygmoCor® system which noninvasively measures aortic central blood pressures and arterial stiffness, announced today that it has been awarded a Commercialisation Australia grant to help complete the next phase of SphygmoCor's development. The grant is valued at $1.1 million over two years.
The grant will help fund development of AtCor's industry-leading central blood pressure measurement system which includes enhanced features and improved ease of use for clinicians and researchers.
Duncan Ross, AtCor Medical CEO said, "We are delighted to receive this grant and grateful to the Australian Government. This funding will help us accelerate the release of an exciting new product range. Our new technology will strengthen AtCor's ability to penetrate the US$2.2 billion global market. While our new platform technology is driven largely by emerging requirements in clinical practice, it is also complementary to customer feedback from our academic research and pharmaceutical clinical trials market. "

About AtCor Medical

AtCor Medical develops and markets products for the early detection of cardiovascular risk and management of cardiovascular disease. Its technology allows researchers and clinicians to measure central blood pressure non-invasively. The company's SphygmoCor® system visibly identifies the effects of reflected blood pressure in the central aortic pressure wave, effects which cannot be detected with standard blood pressure monitoring. More than 2,700 SphygmoCor® systems are currently in use worldwide at major medical institutions, research institutions and in various clinical trials with leading pharmaceutical companies, and the company's technology have been featured in over 600 peer-reviewed studies published in leading medical journals. AtCor has operations in Australia, the United States, and Europe. For further information, please visit our web site at www.atcormedical.com

For further information, please contact:

Duncan Ross - AtCor Medical CEO
[phone]
Peter Manley - AtCor Medical CFO
[phone]

Media enquiries to:

Ashley Rambukwella - Financial & Corporate Relations
Ph: [phone]/ m. 0407 231 282 or [e-mail]